Your browser is no longer supported. Please, upgrade your browser.
TMO [NYSE]
Thermo Fisher Scientific Inc.
IndexS&P 500 P/E28.34 EPS (ttm)21.61 Insider Own0.10% Shs Outstand393.00M Perf Week1.10%
Market Cap239.49B Forward P/E28.79 EPS next Y21.27 Insider Trans-24.07% Shs Float392.63M Perf Month6.22%
Income8.60B PEG2.37 EPS next Q4.67 Inst Own89.70% Short Float0.66% Perf Quarter14.71%
Sales38.25B P/S6.26 EPS this Y73.80% Inst Trans0.21% Short Ratio2.21 Perf Half Y31.85%
Book/sh93.78 P/B6.53 EPS next Y-4.18% ROA12.90% Target Price653.61 Perf Year25.14%
Cash/sh18.12 P/C33.79 EPS next 5Y11.95% ROE24.90% 52W Range433.52 - 616.93 Perf YTD31.45%
Dividend1.04 P/FCF30.83 EPS past 5Y26.50% ROI12.30% 52W High-0.75% Beta0.71
Dividend %0.17% Quick Ratio2.10 Sales past 5Y13.70% Gross Margin51.30% 52W Low41.24% ATR12.72
Employees80000 Current Ratio2.80 Sales Q/Q34.10% Oper. Margin28.00% RSI (14)68.10 Volatility1.82% 1.93%
OptionableYes Debt/Eq0.51 EPS Q/Q58.90% Profit Margin22.50% Rel Volume1.52 Prev Close608.34
ShortableYes LT Debt/Eq0.51 EarningsOct 27 BMO Payout4.20% Avg Volume1.16M Price612.29
Recom1.80 SMA204.51% SMA506.32% SMA20020.56% Volume1,767,592 Change0.65%
Oct-20-21Upgrade Citigroup Neutral → Buy $620 → $700
Oct-15-21Resumed Cowen Outperform $655 → $696
Aug-05-21Resumed Credit Suisse Outperform $580
Jul-16-21Initiated The Benchmark Company Buy $580
Mar-18-21Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Mar-03-21Initiated Barclays Overweight $525
Jan-08-21Upgrade Credit Suisse Neutral → Outperform $490 → $556
Dec-16-20Downgrade Citigroup Buy → Neutral $550 → $500
Dec-02-20Initiated Goldman Buy $570
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $550
Sep-30-20Initiated Atlantic Equities Overweight $494
Sep-14-20Initiated Morgan Stanley Overweight $485
Aug-20-20Resumed JP Morgan Overweight $460
Jul-15-20Upgrade Cleveland Research Neutral → Buy
Jul-07-20Reiterated Needham Buy $383 → $415
Apr-23-20Reiterated Needham Buy $341 → $383
Jan-31-20Reiterated Needham Buy $331 → $341
Jan-22-20Initiated Credit Suisse Neutral $341
Jan-08-20Initiated Wells Fargo Equal Weight $350
Jan-07-20Initiated Citigroup Buy $380
Oct-27-21 03:03PM  
10:58AM  
08:30AM  
07:15AM  
06:51AM  
06:26AM  
06:19AM  
06:00AM  
Oct-26-21 10:14AM  
08:00AM  
06:14AM  
Oct-25-21 08:04PM  
11:44AM  
08:58AM  
08:00AM  
Oct-22-21 10:22AM  
08:38AM  
Oct-21-21 05:50PM  
01:55PM  
Oct-20-21 03:03PM  
Oct-19-21 08:36PM  
08:58AM  
08:00AM  
Oct-15-21 11:15AM  
09:10AM  
06:45AM  
Oct-14-21 05:50PM  
11:04AM  
08:20AM  
06:53AM  
Oct-13-21 11:10AM  
06:30AM  
Oct-12-21 11:30AM  
09:10AM  
Oct-11-21 04:00PM  
08:50AM  
Oct-08-21 07:40AM  
Oct-07-21 05:50PM  
12:10PM  
10:00AM  
Oct-06-21 06:20PM  
09:05AM  
Oct-05-21 02:21PM  
09:34AM  
Oct-04-21 03:00PM  
01:00PM  
08:52AM  
Oct-01-21 01:28PM  
06:00AM  
Sep-30-21 10:16AM  
09:37AM  
Sep-29-21 02:35PM  
10:26AM  
08:00AM  
Sep-27-21 09:59AM  
Sep-25-21 11:45AM  
Sep-23-21 04:05PM  
Sep-22-21 06:20AM  
Sep-21-21 10:07PM  
10:42AM  
08:50AM  
08:00AM  
07:53AM  
Sep-20-21 03:44PM  
09:28AM  
08:30AM  
08:00AM  
Sep-17-21 04:06PM  
01:50PM  
12:06PM  
10:55AM  
Sep-16-21 09:40AM  
06:08AM  
Sep-15-21 08:33AM  
Sep-10-21 11:05AM  
Sep-09-21 04:33PM  
09:39AM  
Sep-07-21 04:05PM  
Sep-06-21 09:56AM  
Sep-03-21 09:09AM  
Sep-02-21 01:14PM  
09:10AM  
08:00AM  
Sep-01-21 05:50PM  
Aug-31-21 01:15PM  
Aug-27-21 11:31AM  
09:18AM  
Aug-26-21 05:50PM  
12:17PM  
Aug-24-21 11:44AM  
09:26AM  
Aug-19-21 10:30AM  
Aug-18-21 10:10AM  
Aug-10-21 02:37PM  
09:53AM  
Aug-09-21 06:10PM  
10:12AM  
08:38AM  
Aug-06-21 11:28AM  
Aug-05-21 12:36PM  
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Holmes Joseph R.VP & Chief Accounting OfficerAug 09Option Exercise198.21759150,4401,372Aug 10 04:18 PM
Holmes Joseph R.VP & Chief Accounting OfficerAug 09Sale542.75759411,948897Aug 10 04:18 PM
CASPER MARC NChairman & CEOAug 05Sale539.9310,0005,399,345189,060Aug 06 04:29 PM
CASPER MARC NChairman & CEOAug 04Sale539.0510,0005,390,468199,060Aug 06 04:29 PM
CASPER MARC NChairman & CEOAug 03Sale535.7310,0005,357,276209,060Aug 04 04:25 PM
Stevenson MarkExecutive Vice President & COOAug 02Option Exercise175.4626,9254,724,37489,279Aug 04 04:22 PM
CASPER MARC NChairman & CEOAug 02Sale535.4610,0005,354,584219,060Aug 04 04:25 PM
Stevenson MarkExecutive Vice President & COOAug 02Sale535.3826,92514,415,22062,354Aug 04 04:22 PM
MANZI JIM PDirectorJul 30Sale536.54572306,89917,752Aug 02 04:05 PM
Lagarde MichelExecutive Vice PresidentMay 10Option Exercise190.5921,6004,116,74440,061May 11 04:44 PM
Lagarde MichelExecutive Vice PresidentMay 10Sale464.5121,60010,033,51818,461May 11 04:44 PM
Lagarde MichelExecutive Vice PresidentMay 07Option Exercise190.5929,1005,546,16952,629May 11 04:44 PM
Lagarde MichelExecutive Vice PresidentMay 07Sale472.6034,16816,147,63618,461May 11 04:44 PM
Lagarde MichelExecutive Vice PresidentFeb 12Sale507.797,2903,701,78915,775Feb 17 04:01 PM
Stevenson MarkExecutive Vice President & COODec 07Option Exercise129.7723,8253,091,77067,717Dec 08 04:31 PM
Stevenson MarkExecutive Vice President & COODec 07Sale473.8414,1336,696,78153,584Dec 08 04:31 PM
Stevenson MarkExecutive Vice President & COODec 04Option Exercise129.7723,8253,091,77058,005Dec 08 04:31 PM
Stevenson MarkExecutive Vice President & COODec 04Sale476.4614,1136,724,28043,892Dec 08 04:31 PM
CASPER MARC NChairman & CEONov 02Sale484.0915,0007,261,35054,330Nov 04 04:09 PM